Catalyst Wire Dossier Catalyst Wire Dossier

SYNJARDY

empagliflozin and metformin hydrochloride · Boehringer Ingelheim Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for SYNJARDY, covering 2015-07-24 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing